Adirondack Trust Company’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78K | Hold |
100
| – | – | ﹤0.01% | 459 |
|
|
2025
Q1 | $1.78K | Hold |
100
| – | – | ﹤0.01% | 455 |
|
|
2024
Q4 | $2.98K | Hold |
100
| – | – | ﹤0.01% | 439 |
|
|
2024
Q3 | $1.56K | Hold |
100
| – | – | ﹤0.01% | 471 |
|
|
2024
Q2 | $1.71K | Hold |
100
| – | – | ﹤0.01% | 466 |
|
|
2024
Q1 | $1.56K | Hold |
100
| – | – | ﹤0.01% | 480 |
|
|
2023
Q4 | $1.53K | Hold |
100
| – | – | ﹤0.01% | 475 |
|
|
2023
Q3 | $1.61K | Hold |
100
| – | – | ﹤0.01% | 459 |
|
|
2023
Q2 | $3.26K | Hold |
100
| – | – | ﹤0.01% | 417 |
|
|
2023
Q1 | $6.01K | Hold |
100
| – | – | ﹤0.01% | 384 |
|
|
2022
Q4 | $7.34K | Hold |
100
| – | – | ﹤0.01% | 360 |
|
|
2022
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 349 |
|
|
2022
Q2 | $7K | Hold |
100
| – | – | ﹤0.01% | 355 |
|
|
2022
Q1 | $8K | Hold |
100
| – | – | ﹤0.01% | 346 |
|
|
2021
Q4 | $8K | Hold |
100
| – | – | ﹤0.01% | 316 |
|
|
2021
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 317 |
|
|
2021
Q2 | $22K | Hold |
100
| – | – | 0.01% | 243 |
|
|
2021
Q1 | $13K | Hold |
100
| – | – | 0.01% | 275 |
|
|
2020
Q4 | $16K | Hold |
100
| – | – | 0.01% | 252 |
|
|
2020
Q3 | $11K | Hold |
100
| – | – | 0.01% | 241 |
|
|
2020
Q2 | $8K | Hold |
100
| – | – | 0.01% | 263 |
|
|
2020
Q1 | $7K | Hold |
100
| – | – | 0.01% | 254 |
|
|
2019
Q4 | $8K | Hold |
100
| – | – | 0.01% | 265 |
|
|
2019
Q3 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 274 |
|